Telmisartan effectively improves insulin sensitivity in hypertensive patients with insulin resistance

Obesity Research and Clinical Practice

Volumn 5, Issue 4, 2011, Pages

  Shinohara, Tetsuji ^a   Takahashi, Naohiko ^a   Abe, Ichitaro ^a   Okada, Norihiro ^a   Wakisaka, Osamu ^a   Yufu, Kunio ^a   Hara, Masahide ^a   Nakagawa, Mikiko ^a   Saikawa, Tetsunori ^a   Yoshimatsu, Hironobu ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Adiponectin; Drug therapy; Hypertension; Insulin resistance

Indexed keywords

ADIPONECTIN; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; C REACTIVE PROTEIN; INSULIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TELMISARTAN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG MECHANISM; ECHOCARDIOGRAPHY; FEMALE; HUMAN; HYPERTENSION; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; METABOLIC PARAMETERS; PRIORITY JOURNAL;

EID: 80054799272     PISSN: 1871403X     EISSN: 18780318     Source Type: Journal    
DOI: 10.1016/j.orcp.2011.03.011     Document Type: Article

References (40)

1. F.X. Pi-Sunyer The epidemiology of central fat distribution in relation to disease Nutr Rev 62 2004 120 126
2. J.R. Sowers Insulin resistance and hypertension Am J Physiol Heart Circ Physiol 286 2004 1597 1602
3. M. Chandran, S.A. Phillips, T. Ciaraldi, and R.R. Henry Adiponectin: more than just another fat cell hormone? Diabetes Care 26 2003 2442 2450 (Pubitemid 36993340)
4. K. Hotta, T. Funahashi, Y. Arita, M. Takahashi, M. Matsuda, and Y. Okamoto Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients Arterioscler Thromb Vasc Biol 20 2000 1595 1599 (Pubitemid 30353893)
5. Y. Arita, S. Kihara, N. Ouchi, M. Takahashi, K. Maeda, and J. Miyagawa Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity Biochem Biophys Res Commun 257 1999 79 83 (Pubitemid 29299050)
6. M. Kumada, S. Kihara, S. Sumitsuji, T. Kawamoto, S. Matsumoto, and N. Ouchi Association of hypoadiponectinemia with coronary artery disease in men Arterioscler Thromb Vasc Biol 23 2003 85 89 (Pubitemid 36091630)
7. B.M. Spiegelman, and R. Heinrich Biological control through regulated transcriptional coactivators Cell 119 2004 157 167 (Pubitemid 39360899)
8. F. Picard, and J. Auwerx PPAR(gamma) and glucose homeostasis Annu Rev Nutr 22 2002 167 197
9. S.C. Benson, H.A. Pershadsingh, C.I. Ho, A. Chittiboyina, P. Desai, and M. Pravenec Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity Hypertension 43 2004 993 1002 (Pubitemid 38579904)
10. M. Schupp, J. Janke, R. Clasen, T. Unger, and U. Kintscher Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-gamma activity Circulation 109 2004 2054 2057 (Pubitemid 38620211)
11. M. Schupp, M. Clemenz, R. Gineste, H. Witt, J. Janke, and S. Helleboid Molecular characterization of new selective peroxisome proliferator-activated receptor gamma modulators with angiotensin receptor blocking activity Diabetes 54 2005 3442 3452 (Pubitemid 43334334)
12. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, and R.C. Turner Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 412 419 (Pubitemid 15018832)
13. D.J. Sahn, A. DeMaria, J. Kisslo, and A. Weyman Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements Circulation 58 1978 1072 1083 (Pubitemid 9091990)
14. R.B. Devereux, D.R. Alonso, E.M. Lutas, G.J. Gottlieb, E. Campo, and I. Sachs Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings Am J Cardiol 57 1986 450 458 (Pubitemid 16119719)
15. K. Maeda, K. Okubo, I. Shimomura, T. Funahashi, Y. Matsuzawa, and K. Matsubara cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1) Biochem Biophys Res Commun 221 1996 286 289 (Pubitemid 26136463)
16. R.R. Banerjee, S.M. Rangwala, J.S. Shapiro, A.S. Rich, B. Rhoades, and Y. Qi Regulation of fasted blood glucose by resistin Science 303 2004 1195 1198 (Pubitemid 38233585)
17. T. Kadowaki, and T. Yamauchi Adiponectin and adiponectin receptors Endocr Rev 26 2005 439 451 (Pubitemid 40686653)
18. T. Masaki, S. Chiba, H. Tatsukawa, T. Yasuda, H. Noguchi, and M. Seike Adiponectin protects LPS-induced liver injury through modulation of TNF-alpha in KK-Ay obese mice Hepatology 40 2004 177 184 (Pubitemid 38868936)
19. N. Riera-Guardia, and D. Rothenbacher The effect of thiazolidinediones on adiponectin serum level: a meta-analysis Diabetes Obes Metab 10 2008 367 375 (Pubitemid 351524284)
20. T. Shiuchi, M. Iwai, H.S. Li, L. Wu, L.J. Min, and J.M. Li Angiotensin II type-1 receptor blocker valsartan enhances insulin sensitivity in skeletal muscles of diabetic mice Hypertension 43 2004 1003 1010 (Pubitemid 38579905)
21. O. Bahadir, M. Uzunlulu, A. Oguz, and M.A. Bahadir Effects of telmisartan and losartan on insulin resistance in hypertensive patients with metabolic syndrome Hypertens Res 30 2007 49 53
22. M. Watanabe, K. Inukai, T. Sumita, K. Ikebukuro, D. Ito, and S. Kurihara Effects of telmisartan on insulin resistance in Japanese type 2 diabetic patients Intern Med 49 2010 1843 1847
23. N. Komiya, H. Hirose, H. Kawabe, H. Itoh, and I. Saito Effects of telmisartan therapy on metabolic profiles and serum high molecular weight (hmw)-adiponectin level in Japanese male hypertensive subjects with abdominal obesity J Atheroscler Thromb 16 2009 137 142
24. F. Anan, N. Takahashi, T. Ooie, K. Yufu, T. Saikawa, and H. Yoshimatsu Role of insulin resistance in nondipper essential hypertensive patients Hypertens Res 26 2003 669 676 (Pubitemid 37258652)
25. Y. Ikeda, T. Nakamura, H. Takano, H. Kimura, J.E. Obata, and S. Takeda Angiotensin II-induced cardiomyocyte hypertrophy and cardiac fibrosis in stroke-prone spontaneously hypertensive rats J Lab Clin Med 135 2000 353 359 (Pubitemid 30213552)
26. C. Shikata, A. Takeda, and N. Takeda Effect of an ACE inhibitor and an AT1 receptor antagonist on cardiac hypertrophy Mol Cell Biochem 248 2003 197 202 (Pubitemid 36833660)
27. T.M. Seccia, A.S. Belloni, R. Kreutz, M. Paul, G.G. Nussdorfer, and A.C. Pessina Cardiac fibrosis occurs early and involves endothelin and AT-1 receptors in hypertension due to endogenous angiotensin II J Am Coll Cardiol 41 2003 666 673 (Pubitemid 36223335)
28. M. Asakawa, H. Takano, T. Nagai, H. Uozumi, H. Hasegawa, and N. Kubota Peroxisome proliferator-activated receptor gamma plays a critical role in inhibition of cardiac hypertrophy in vitro and in vivo Circulation 105 2002 1240 1246 (Pubitemid 34225827)
29. P.M. Ridker High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease Circulation 103 2001 1813 1818 (Pubitemid 32291421)
30. G.J. Blake, and P.M. Ridker C-reactive protein and other inflammatory risk markers in acute coronary syndromes J Am Coll Cardiol 41 2003 37 42
31. S. Verma, S.H. Li, M.V. Badiwala, R.D. Weisel, P.W. Fedak, and R.K. Li Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein Circulation 105 2002 1890 1896 (Pubitemid 34437614)
32. S. Verma, C.H. Wang, S.H. Li, A.S. Dumont, P.W. Fedak, and M.V. Badiwala A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis Circulation 106 2002 913 919 (Pubitemid 34925323)
33. C.H. Wang, S.H. Li, R.D. Weisel, P.W. Fedak, A.S. Dumont, and P. Szmitko C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle Circulation 107 2003 1783 1790 (Pubitemid 36418360)
34. A. Prasad, K.K. Koh, W.H. Schenke, R. Mincemoyer, G. Csako, and T.A. Fleischer Role of angiotensin II type 1 receptor in the regulation of cellular adhesion molecules in atherosclerosis Am Heart J 142 2001 248 253 (Pubitemid 32706282)
35. K.K. Koh, J.Y. Ahn, S.H. Han, D.S. Kim, D.K. Jin, and H.S. Kim Pleiotropic effects of angiotensin II receptor blocker in hypertensive patients J Am Coll Cardiol 42 2003 905 910 (Pubitemid 37059752)
36. M. Ricote, A.C. Li, T.M. Willson, C.J. Kelly, and C.K. Glass The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation Nature 391 1998 79 82 (Pubitemid 28079218)
37. C. Jiang, A.T. Ting, and B. Seed PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines Nature 391 1998 82 86 (Pubitemid 28079219)
38. S.P. Weisberg, D. McCann, M. Desai, M. Rosenbaum, R.L. Leibel, and A.W. Ferrante Obesity is associated with macrophage accumulation in adipose tissue J Clin Invest 112 2003 1796 1808 (Pubitemid 38063703)
39. S. Engeli, M. Feldpausch, K. Gorzelniak, F. Hartwig, U. Heintze, and J. Janke Association between adiponectin and mediators of inflammation in obese women Diabetes 52 2003 942 947 (Pubitemid 36384264)
40. Y. Zhao, X. He, C. Huang, X. Fu, X. Shi, and Y. Wu The impacts of thiazolidinediones on circulating C-reactive protein levels in different diseases: a meta-analysis Diabetes Res Clin Pract 90 2010 279 287